edits.seer.internal.rules.IF373.xml Maven / Gradle / Ivy

Go to download
Show more of this group Show more artifacts with this name
Show all versions of validation-edits-seer Show documentation
Java implemenation of the SEER edits.
There is a newer version: 024-13
Show newest version
        <rule id="IF373" name="CS SSF 21, TS/Ext Eval, LN Eval, Breast (CS)" tag="N1561" java-path="lines.line" category="inter-field" depends="Behavior_Code_ICD-O-3,CS_Reg_Node_Eval,CS_Site-Specific_Factor_21,CS_Site-Specific_Factor_25,CS_Tumor_Size_Ext_Eval,Histologic_Type_ICD-O-3,Primary_Site">
            <expression><![CDATA[if (line.csSiteSpecificFactor21 == null || line.csSiteSpecificFactor21 == '988' || line.csTumorSizeExtEval == null || line.csLymphNodesEval == null ||
    line.behaviorCodeIcdO3 == '0' || line.behaviorCodeIcdO3 == '1' || line._csSchemaId == null)
    return true

if (line._csSchemaId == 'breast') {
    if (Functions.matches(line.csSiteSpecificFactor21, /^(0[123]0)$/))
        return line.csTumorSizeExtEval == '5' || line.csTumorSizeExtEval == '6' || line.csLymphNodesEval == '5' || line.csLymphNodesEval == '6'
    if (line.csSiteSpecificFactor21 == '987')
        return line.csTumorSizeExtEval != '5' && line.csTumorSizeExtEval != '6' && line.csLymphNodesEval != '5' && line.csLymphNodesEval != '6'
}

return true]]></expression>
            <message>CS SSF21, TS/Ext Eval and LN eval conflict for Breast</message>
            <description><![CDATA[This edit applies only to cases coded using the Breast schema. If SSF 21 (Response to Neoadjuvant Therapy) indicates the patient received neoadjuvant therapy, then either Tumor Size/Ext Eval or Lymph Nodes Eval must indicate the patient received neoadjuvant therapy. If SSF 21 indicates the patient did not receive neoadjuvant therapy, then both Tumor Size/Ext Eval and Lymph Nodes Eval must also indicate no neoadjuvant therapy.

This edit is skipped if any of the following conditions are true:
1. CS Site-Specific Factor21 is blank or 988
2. CS TS/Ext Eval is blank
3. CS Lymph Nodes Eval is blank
3. Behavior Code ICD-O-3 = 0 (benign) or 1 (borderline)
4. CS schema is invalid

This edit first determines the correct CS schema by doing a function call to the CS Dynamic Link Library (dll). The function call passes Primary Site, Histologic Type ICD-O-3, and CS Site-Specific Factor25 (schema discriminator) to the dll and the CS schema name is returned.

If CS schema is Breast:
1. If CS Site-Specific Factor21 = 010, 020, or 030 (received neoadjuvant therapy), then either CS Tumor Size/Ext Eval or CS Lymph Nodes Eval must = 5 or 6 indicating patient received neoadjuvant therapy.
2. If CS Site-Specific Factor21 = 987 (neoadjuvant therapy not given), then CS Tumor Size/Ext Eval and CS Lymph Nodes Eval must not = 5 or 6.]]></description>
            <history>
                <event version="SE12-005-01" user="murphyr" date="2011-08-03" ref="66487">Edit created.</event>
                <event version="SE12-008-04" user="depryf" date="2012-10-23" ref="66763">Disabled this edit. The edit is being reviewed by the Edits Committee. It will be re-activated after changes are made to the logic.</event>
                <event version="SE13-009-01" user="murphyr" date="2013-01-25" ref="66826">Edit name changed.</event>
                <event version="SE16-015-01" user="kirbyk" date="2016-05-04" ref="67370">Changed edit to use schema IDs instead of schema names</event>
                <event version="SE16-015-01" user="kirbyk" date="2016-06-14" ref="67469">Enabled edit.</event>
                <event version="SE16-016-08" user="depryf" date="2017-11-22" ref="67674">Edit syntax updated to allow pre-compilation optimization; no change in behavior.</event>
                <event version="SE18-020-01" user="depryf" date="2020-02-04" ref="68281">Changed property names to align with NAACCR XML IDs.</event>
            </history>
        </rule>